NEW YORK (GenomeWeb) – Biocept reported after the close of the market on Tuesday that its first quarter revenues fell 53 percent year over year.

For the three months ended March 31, the San Diego-based liquid biopsy firm logged $806,943 in revenues compared to $1.7 million a year ago. Q1 revenues included about $762,000 in commercial test revenues and $45,000 in development services test revenues.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.